About
The Story of Quasar
Quasar specializes in the manufacture of products for the medical device market, catheters, electronics and disposables.
Founded in Hong Kong in 1988 by Boaz Amitai, the company was created to serve as a connection between its European, American and Israeli customers and Chinese electronics manufacturers.
Following four years of acquiring in-depth experience and insight from working with Chinese manufacturers, the growth of its customer base in new fields led to a significant expansion, and a factory was established in Shenzhen, China in 1992. In 2005, Boaz passed the reins to his son Ayal, who now lives with his family in Hong Kong.
Vision and Values
Quasar Vision
To provide continual, optimal, full turnkey manufacturing solutions through designing trouble-free processes, utilizing our extensive production experience, creative engineering and world class quality.
Quasar Values
To be able to ensure and maintain a high quality of production, we have a solid set of values that guides the way.
Market Segment
Minimally invasive device
Highly specialized, minimally invasive medical catheters.
Cardio vascular catheters, invasive navigation sensors, disposable colonoscopy catheters.
Disposable device
Superior quality, single-use medical devices.
Respiratory tube sets, aesthetic tips, aesthetic home use cartridges.
Electronic device
Complex medical devices that require highly skilled manual, semi and full automated assembly. Blood pressure monitors, Pulse oximeters, Cosmetic home use devices.
Services
NPD
Design for manufacture (DFM) review and pre – process failure mode effect analysis (Pre-PFMEA),which provide a clear process flow diagram (PFD), assembly steps, critical stages and identify test processes. This preliminary stage removes major barriers at the initial mass production stage.
NPI
Preliminary production portfolio comprising descriptions of the full production process, engineering conclusions, expected challenges and recommendations for production. These advanced processes enable a seamless product transfer from design to production, which ultimately leads to significantly increased efficiency and reduced costs.
FTK
Complete manufacturing solutions from the end of the development phase, through the transition from development to production, and on to the mass production phase. Accompanying the product from its inception until it reaches the production line enables not only optimization of the production process and the meeting of schedules and budgets, but also compliance with the high quality standard that Quasar ensures.
Quality
The main value that Quasar focuses on throughout the entire production process is quality. Quality manufacturing
in China is a matter that is complex, atypical, and difficult to implement. Quality starts during development and
product planning, but it must be maintained during the transition from the development phase to manufacturing.
Quasar meets the ISO standards relevant to the product, as well as cGMP requirements.
Customers
Learning Center
Embolization Coiling: The Importance of Material selection
Embolization coiling is a minimally invasive catheter-based procedure that employs a coil that can cause an occlusion. What’s important is that the design is made easy to handle and produces the desired effect at the intended location.
China MAH Policy Changes and The massive Opportunity for Medical Device OEMs
The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.
Embolization Coiling: The Importance of Material selection
Embolization coiling is a minimally invasive catheter-based procedure that employs a coil that can cause an occlusion. What’s important is that the design is made easy to handle and produces the desired effect at the intended location.
China MAH Policy Changes and The massive Opportunity for Medical Device OEMs
The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.
Israel
6 Hayezira St, Yokneam
Hong Kong
19 Cheung Shun St
Cheung Sha Wan, Kowloon
China Shenzhen
Nangang Industrial Park Phase 1, Xili Town, Nanshan District
USA
12800 Whitewater drive, STE 100, Minnetonka, MN 55343
Tel: +1 (952) 522-0003 | (952)522-4751
Toll-Free: (888) 986-4751
Thailand
340/1 Moo 6, Bowin, Sriracha, Chonburi 20230 Thailand
Tel (+66) 3811-1709
China Dongguan
SSL Medical Park
Industrial Development Park